Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma
Top Cited Papers
- 28 June 2009
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 27 (7) , 633-641
- https://doi.org/10.1038/nbt.1546
Abstract
Although multiple reaction monitoring (MRM) mass spectrometry holds considerable promise for quantifying candidate protein biomarkers in blood, transferability of MRM assays between laboratories has never been shown. Addona et al. assess the reproducibility, dynamic range and limits of detection and quantification of MRM across multiple sites. Verification of candidate biomarkers relies upon specific, quantitative assays optimized for selective detection of target proteins, and is increasingly viewed as a critical step in the discovery pipeline that bridges unbiased biomarker discovery to preclinical validation. Although individual laboratories have demonstrated that multiple reaction monitoring (MRM) coupled with isotope dilution mass spectrometry can quantify candidate protein biomarkers in plasma, reproducibility and transferability of these assays between laboratories have not been demonstrated. We describe a multilaboratory study to assess reproducibility, recovery, linear dynamic range and limits of detection and quantification of multiplexed, MRM-based assays, conducted by NCI-CPTAC. Using common materials and standardized protocols, we demonstrate that these assays can be highly reproducible within and across laboratories and instrument platforms, and are sensitive to low μg/ml protein concentrations in unfractionated plasma. We provide data and benchmarks against which individual laboratories can compare their performance and evaluate new technologies for biomarker verification in plasma.Keywords
This publication has 37 references indexed in Scilit:
- Multiple Reaction Monitoring-based, Multiplexed, Absolute Quantitation of 45 Proteins in Human PlasmaMolecular & Cellular Proteomics, 2009
- Developing Multiplexed Assays for Troponin I and Interleukin-33 in Plasma by Peptide Immunoaffinity Enrichment and Targeted Mass SpectrometryClinical Chemistry, 2009
- Quantification of Thyroglobulin, a Low-Abundance Serum Protein, by Immunoaffinity Peptide Enrichment and Tandem Mass SpectrometryClinical Chemistry, 2008
- Use of an Immunoaffinity-Mass Spectrometry-based Approach for the Quantification of Protein Biomarkers from Serum Samples of Lung Cancer PatientsMolecular & Cellular Proteomics, 2008
- The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipelineProteomics – Clinical Applications, 2008
- Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope DilutionMolecular & Cellular Proteomics, 2007
- Research Profile: A new pipeline for biomarker discovery and validationJournal of Proteome Research, 2007
- Integrated Pipeline for Mass Spectrometry-Based Discovery and Confirmation of Biomarkers Demonstrated in a Mouse Model of Breast CancerJournal of Proteome Research, 2007
- Protein biomarker discovery and validation: the long and uncertain path to clinical utilityNature Biotechnology, 2006
- Performance Characteristics of Seven Automated CA 15-3 AssaysAmerican Journal of Clinical Pathology, 2006